Simpson Curran sold RGNX
October 9, 2025 · Form 4 insider transaction
Simpson Curran sold 20,811 shares of REGENXBIO Inc. at $12.62 per share, a transaction worth $262.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
20,811
Price
$12.62
Total value
$262.6K
InsiderSimpson Curran
RoleOfficer, Director
CompanyREGENXBIO Inc. (RGNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 9, 2025
Filing dateOctober 10, 2025
Shares owned after216,162
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan.; This transaction was executed in multiple trades at prices ranging from $12.50 to $12.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.